Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
CytoSorbents
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
04 mars 2025 07h00 HE
|
CytoSorbents
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
26 févr. 2025 07h00 HE
|
CytoSorbents
CytoSorbents Announces Fourth Quarter and Full Year 2024 Earnings Release Date for March 6, 2025
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
25 févr. 2025 07h00 HE
|
CytoSorbents
CytoSorbents Strengthens Balance Sheet with Additional $1.6M in Aggregate Gross Proceeds from Shareholder Exercise of Series A Right Warrant
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
13 janv. 2025 07h00 HE
|
CytoSorbents
CytoSorbents Strengthens Balance Sheet by $11.25M in Unrestricted Cash through Oversubscribed Shareholder Rights Offering and Satisfied Debt Covenant
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
06 janv. 2025 07h00 HE
|
CytoSorbents
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai, United Arab Emirates, a Gateway to the Middle East and Africa
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
03 janv. 2025 07h00 HE
|
CytoSorbents
CytoSorbents' Preliminary Unaudited Q4 2024 Product Revenue Increased 22-25% From A Year Ago With Product Gross Margins Of ~70%
CytoSorbents Rights Offering Begins
23 déc. 2024 07h00 HE
|
CytoSorbents
CytoSorbents Rights Offering Begins. Eligible Stockholders are Being Distributed a Dividend of Subscription Rights Based on Shares of CTSO Held.
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
12 déc. 2024 07h00 HE
|
CytoSorbents
CytoSorbents Is Scheduling In-Person Investor Meetings During the JP Morgan Healthcare Conference from Jan 13-15, 2025 in San Francisco.
CytoSorbents Announces Rights Offering
09 déc. 2024 07h00 HE
|
CytoSorbents
CytoSorbents Announces Rights Offering Exclusive to Stockholders Who Hold or Have Bought CTSO Common Stock by Market Close on Friday, December 13, 2024
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference
26 nov. 2024 07h00 HE
|
CytoSorbents
CytoSorbents to Participate in the Piper Sandler 36th Annual Healthcare Conference. Management holding one-on-one meetings with investors